Ethicon completed its $3.4bn acquisition of Auris Health.

Ethicon, a subsidiary of Johnson & Johnson, a manufacturer of surgical sutures and wound closure devices, completed its $3.4bn acquisition of Auris Health, a robotic medical company. Additional contingent payments of up to $2.3bn, in the aggregate, may be payable upon reaching certain predetermined milestones. “We are focused on building a connected, data-driven digital ecosystem that pairs our market-leading surgical solutions with advanced technologies to improve the patient experience. The passionate team and differentiated innovation from Auris will help us amplify the power of digital surgery to address unmet clinical needs and lead a transformation in surgical care and lung cancer intervention,” Ashley McEvoy, Johnson & Johnson Executive Vice President and Worldwide Chairman.